Label: DIBUCAINE ointment
- NDC Code(s): 71399-2829-1, 71399-2829-2
- Packager: Akron Pharma Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated January 12, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Uses
- Warninigs
- Do not use
-
When using this product
- avoid contact wnh eyes
- do not use more than directed unless directed by a doctor
- do not put this product into the rectum by using fingers or any mechanical device or applicator
lf pregnant or breast feeding, ask a health care professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Stop use and ask a doctor if
- bleeding occurs
- condition worsens or does not improve wnhin 7 days
-
Directions
- adults and children 12 years and over: if possible, clean the affected area with mild soap and wann water and nnse thoroughly. Dry by patting or blotting withh toilet tissue or a soft cloth before applying.
- apply externally to the affected area up to 3 or 4 times daily
- children under 12 years of age: ask a doctor
- Inactive Ingredients
- STORAGE AND HANDLING
- Questions or Comments?
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
DIBUCAINE
dibucaine ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:71399-2829 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DIBUCAINE (UNII: L6JW2TJG99) (DIBUCAINE - UNII:L6JW2TJG99) DIBUCAINE 0.28 g in 28 g Inactive Ingredients Ingredient Name Strength LANOLIN (UNII: 7EV65EAW6H) LIGHT MINERAL OIL (UNII: N6K5787QVP) WATER (UNII: 059QF0KO0R) WHITE PETROLATUM (UNII: B6E5W8RQJ4) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:71399-2829-1 28 g in 1 TUBE; Type 0: Not a Combination Product 01/06/2025 2 NDC:71399-2829-2 1 in 1 PACKAGE 01/06/2025 2 56 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M015 01/06/2025 Labeler - Akron Pharma Inc. (067878881)